Lilly to Discontinue Development of Evacetrapib
|
2
|
Resverlogix Corp.
|
Oct 12, 2015 08:54AM
|
Re: looks like poc/cutt...
|
1
|
Resverlogix Corp.
|
Oct 07, 2015 02:52PM
|
Re: Explanation of difference between Endcrinology and CVD
|
7
|
Resverlogix Corp.
|
Oct 06, 2015 02:51PM
|
Re: Explanation of difference between Endcrinology and CVD
|
2
|
Resverlogix Corp.
|
Oct 05, 2015 11:32AM
|
Explanation of difference between Endcrinology and CVD
|
3
|
Resverlogix Corp.
|
Oct 05, 2015 06:43AM
|
Re: Resverlogix_150929_C... (Rough, UNOFFICIAL transcript)
|
8
|
Resverlogix Corp.
|
Oct 02, 2015 09:10AM
|
Share price performance in context
|
13
|
Resverlogix Corp.
|
Oct 02, 2015 06:38AM
|
Re: ...is anybody out there at the AGM...?
|
3
|
Resverlogix Corp.
|
Oct 01, 2015 12:03PM
|
Question on EMA vs FDA
|
10
|
Resverlogix Corp.
|
Sep 30, 2015 09:32AM
|
Re: Snippet on Alexion / Soliris
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 11:16AM
|
Snippet on Alexion / Soliris
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 10:47AM
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
9
|
Resverlogix Corp.
|
Sep 27, 2015 11:11AM
|
Re: Steady as she goes....
|
7
|
Resverlogix Corp.
|
Sep 24, 2015 12:14PM
|
I am very excited
|
5
|
Resverlogix Corp.
|
Sep 24, 2015 09:10AM
|
Re: Orphan Disease Announcement
|
3
|
Resverlogix Corp.
|
Sep 24, 2015 08:54AM
|
Re: Orphan Disease Announcement
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 08:49AM
|
Re: Orphan Disease Announcement
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 08:30AM
|
Re: Orphan Disease Announcement
|
5
|
Resverlogix Corp.
|
Sep 24, 2015 08:23AM
|
Re: Orphan Disease Announcement
|
3
|
Resverlogix Corp.
|
Sep 24, 2015 07:12AM
|
Braveheart
|
9
|
Resverlogix Corp.
|
Sep 21, 2015 02:30PM
|